- Email: [email protected]
Recent Advances in Reducing the Burden of Herpes Zoster and Postherpetic Neuralgia
The Journal of Pain, Vol 9, No 1 (January), Supplement 1, 2008: pp S45-S47 Available online at www.sciencedirect.com
EVALUATION FORM—SCI-ZOS-0304 Recent Advances in Reducing the Burden of Herpes Zoster and Postherpetic Neuralgia POST-TEST 1. Herpes zoster has the highest incidence of all neurological diseases, with a lifetime incidence of: a. 1% b. 5%-10% c. 10%-20% d. 20%-30% 2. Older age and severe acute zoster pain are risk factors for PHN a. True b. False 3. Antiviral therapy of acute zoster outbreaks can: a. Reduce acute zoster pain b. Reduce the duration of the zoster rash c. Reduce the likelihood of PHN, but not prevent it in all cases d. All of the above 4. Postherpetic neuralgia is thought to arise as a result of: a. Damage to the dorsal horn and corresponding neurons that occurs as a result of the acute zoster outbreak b. Complications of infection of zoster pustules c. Having developed chickenpox at a younger age d. Scratching during the acute zoster rash 5. The zoster vaccine has been shown to: a. Reduce the incidence of herpes zoster b. Reduce the incidence of PHN c. Reduce the severity of herpes zoster d. All of the above
S45
S46
CME Information
January 1, 2008 SciMed respects and appreciates your opinion. To assist us in evaluating the effectiveness of this activity and to make recommendations for future educational offerings, please take a few minutes to complete this evaluation form and fax to 212-661-8338, ATTN: CME Department. Circle the appropriate response (5 ⫽ outstanding/extremely; 4 ⫽ good/very; 3 ⫽ satisfactory; 2 ⫽ fair/not very; 1 ⫽ poor/not at all) EXTENT TO WHICH ACTIVITY MET THE IDENTIFIED OBJECTIVES Summarize the natural history and treatment options for herpes zoster 5 4 3 2 1 Describe the risk factors and pain mechanisms of postherpetic neuralgia (PHN), the most common complication of herpes zoster 5 4 3 2 1 Assess the efficacy of current therapies for PHN 5 4 3 2 1 Summarize the current approaches to the diagnosis and assessment of pain associated with herpes zoster 5 4 3 2 1 Discuss the potential benefits of the zoster vaccine in reducing the public health burden of herpes zoster and PHN 5 4 3 2 1 OVERALL EFFECTIVENESS OF THE ACTIVITY The content presented: Was timely and will influence how I practice Will assist me in improving patient care Fulfilled my educational needs Avoided commercial bias or influence
5 5 5 5
4 4 4 4
3 3 3 3
2 2 2 2
1 1 1 1
If you rated “1” or “2” regarding commercial bias, please provide comment(s). ____________________________________________________________________________________________ ____________________________________________________________________________________________ ____________________________________________________________________________________________ Logistically: The format and materials were useful 5 4 3 2 1 What was the most positive part of this activity? ____________________________________________________________________________________________ ____________________________________________________________________________________________ ____________________________________________________________________________________________ IMPACT OF THE ACTIVITY Will your practice change as a result of participating in this activity? e Yes e No Please describe any change(s) you plan to make in your practice as a result of this activity. ____________________________________________________________________________________________ ____________________________________________________________________________________________ ____________________________________________________________________________________________ How committed are you to making these changes?
5
4
3
FUTURE ACTIVITIES Do you feel future activities on this subject matter are necessary and/or important to your practice? 5 4 3
2
1
2
1
Please suggest educational needs or practice-related problems in which you have interest for future activities. ____________________________________________________________________________________________ ____________________________________________________________________________________________ What method of learning do you most prefer? Live meeting (eg, symposium) Enduring materials (eg, monograph, journal supplement) Multimedia (eg, CD-ROM, Web-based activities) Z0S-0304
5 5 5
4 4 4
3 3 3
2 2 2
1 1 1
S47
FOLLOW-UP As part of our continuous quality-improvement effort, we conduct post-activity follow-up surveys to assess the impact of our educational interventions on professional practice. Please indicate your willingness to participate in such a survey: e Yes, I would be interested in participating in a follow-up survey. e No, I would not be interested in participating in a follow-up survey. Additional comments about this activity: ____________________________________________________________________________________________ ____________________________________________________________________________________________ ____________________________________________________________________________________________ REQUEST FOR CREDIT If you wish to receive acknowledgement for participating in this activity, please complete the posttest (select the best answer to each question), along with this evaluation form verifying your participation. The post-test and evaluation form can be faxed to 212-661-8338, ATTN: CME Department. POST-TEST ANSWER KEY (Enter post-test answers below) 1
2
3
4
5
Participant Information: (please print clearly) Last Name _____________________First Name _____________________Degree(s) _____________________ Academic Title ______________________________________________________________________________ Affiliation __________________________________________________________________________________ Specialty____________________________________________________________________________________ Address (No PO boxes, please) ________________________________________________________________ City _______________________State _______________________ZIP/Postal Code _______________________ Phone _________________________Fax _________________________E-mail _________________________ Licensed in__________________________________________________________________________________ Last four digits of your Social Security Number ______________________________________________OR AMA ME Number ___________________________________________________________________________ SciMed is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SciMed designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. I certify that I have participated in the CME activity entitled Recent Advances in Reducing the Burden of Herpes Zoster and Postherpetic Neuralgia for a total of ________________________ hours. ____________________________________________________________________________________________ Signature Date e Yes, I am interested in receiving future educational materials.
Z0S-0304
EVALUATION FORM—SCI-ZOS-0304 Recent Advances in Reducing the Burden of Herpes Zoster and Postherpetic Neuralgia POST-TEST 1. Herpes zoster has the highest incidence of all neurological diseases, with a lifetime incidence of: a. 1% b. 5%-10% c. 10%-20% d. 20%-30% 2. Older age and severe acute zoster pain are risk factors for PHN a. True b. False 3. Antiviral therapy of acute zoster outbreaks can: a. Reduce acute zoster pain b. Reduce the duration of the zoster rash c. Reduce the likelihood of PHN, but not prevent it in all cases d. All of the above 4. Postherpetic neuralgia is thought to arise as a result of: a. Damage to the dorsal horn and corresponding neurons that occurs as a result of the acute zoster outbreak b. Complications of infection of zoster pustules c. Having developed chickenpox at a younger age d. Scratching during the acute zoster rash 5. The zoster vaccine has been shown to: a. Reduce the incidence of herpes zoster b. Reduce the incidence of PHN c. Reduce the severity of herpes zoster d. All of the above
S45
S46
CME Information
January 1, 2008 SciMed respects and appreciates your opinion. To assist us in evaluating the effectiveness of this activity and to make recommendations for future educational offerings, please take a few minutes to complete this evaluation form and fax to 212-661-8338, ATTN: CME Department. Circle the appropriate response (5 ⫽ outstanding/extremely; 4 ⫽ good/very; 3 ⫽ satisfactory; 2 ⫽ fair/not very; 1 ⫽ poor/not at all) EXTENT TO WHICH ACTIVITY MET THE IDENTIFIED OBJECTIVES Summarize the natural history and treatment options for herpes zoster 5 4 3 2 1 Describe the risk factors and pain mechanisms of postherpetic neuralgia (PHN), the most common complication of herpes zoster 5 4 3 2 1 Assess the efficacy of current therapies for PHN 5 4 3 2 1 Summarize the current approaches to the diagnosis and assessment of pain associated with herpes zoster 5 4 3 2 1 Discuss the potential benefits of the zoster vaccine in reducing the public health burden of herpes zoster and PHN 5 4 3 2 1 OVERALL EFFECTIVENESS OF THE ACTIVITY The content presented: Was timely and will influence how I practice Will assist me in improving patient care Fulfilled my educational needs Avoided commercial bias or influence
5 5 5 5
4 4 4 4
3 3 3 3
2 2 2 2
1 1 1 1
If you rated “1” or “2” regarding commercial bias, please provide comment(s). ____________________________________________________________________________________________ ____________________________________________________________________________________________ ____________________________________________________________________________________________ Logistically: The format and materials were useful 5 4 3 2 1 What was the most positive part of this activity? ____________________________________________________________________________________________ ____________________________________________________________________________________________ ____________________________________________________________________________________________ IMPACT OF THE ACTIVITY Will your practice change as a result of participating in this activity? e Yes e No Please describe any change(s) you plan to make in your practice as a result of this activity. ____________________________________________________________________________________________ ____________________________________________________________________________________________ ____________________________________________________________________________________________ How committed are you to making these changes?
5
4
3
FUTURE ACTIVITIES Do you feel future activities on this subject matter are necessary and/or important to your practice? 5 4 3
2
1
2
1
Please suggest educational needs or practice-related problems in which you have interest for future activities. ____________________________________________________________________________________________ ____________________________________________________________________________________________ What method of learning do you most prefer? Live meeting (eg, symposium) Enduring materials (eg, monograph, journal supplement) Multimedia (eg, CD-ROM, Web-based activities) Z0S-0304
5 5 5
4 4 4
3 3 3
2 2 2
1 1 1
S47
FOLLOW-UP As part of our continuous quality-improvement effort, we conduct post-activity follow-up surveys to assess the impact of our educational interventions on professional practice. Please indicate your willingness to participate in such a survey: e Yes, I would be interested in participating in a follow-up survey. e No, I would not be interested in participating in a follow-up survey. Additional comments about this activity: ____________________________________________________________________________________________ ____________________________________________________________________________________________ ____________________________________________________________________________________________ REQUEST FOR CREDIT If you wish to receive acknowledgement for participating in this activity, please complete the posttest (select the best answer to each question), along with this evaluation form verifying your participation. The post-test and evaluation form can be faxed to 212-661-8338, ATTN: CME Department. POST-TEST ANSWER KEY (Enter post-test answers below) 1
2
3
4
5
Participant Information: (please print clearly) Last Name _____________________First Name _____________________Degree(s) _____________________ Academic Title ______________________________________________________________________________ Affiliation __________________________________________________________________________________ Specialty____________________________________________________________________________________ Address (No PO boxes, please) ________________________________________________________________ City _______________________State _______________________ZIP/Postal Code _______________________ Phone _________________________Fax _________________________E-mail _________________________ Licensed in__________________________________________________________________________________ Last four digits of your Social Security Number ______________________________________________OR AMA ME Number ___________________________________________________________________________ SciMed is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SciMed designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. I certify that I have participated in the CME activity entitled Recent Advances in Reducing the Burden of Herpes Zoster and Postherpetic Neuralgia for a total of ________________________ hours. ____________________________________________________________________________________________ Signature Date e Yes, I am interested in receiving future educational materials.
Z0S-0304